Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2012
As of Dec 31, 2012
Q4 FY2011
As of Dec 31, 2011
Q4 FY2010
As of Dec 31, 2010
ASSETS
Current Assets:
Cash and cash equivalents
Restricted cash and cash equivalents - current
Assets held for sale
Accounts receivable
Investment securities - current
Inventory
Deferred tax assets - current
Prepaid and other current assets
Total current assets
Property, plant and equipment, net
Goodwill and other intangible assets, net
Equity method investments
Investment securities - non-current
Restricted cash and cash equivalents - non-current
Deferred tax assets - non-current
Other assets
Total assets
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts payable
Accrued and other current liabilities
Total current liabilities
Long-term debt
Other liabilities
Total liabilities
Shareholders' Equity:
Ordinary Shares, €0.05 par value, 810,000,000 shares authorized 594,949,536 and 589,346,275 shares issued and outstanding at December 31, 2012 and 2011, respectively
"B" Executive Shares, €0.05 par value, 25,000 shares authorized, no shares issued or outstanding at December 31, 2012 and 21,375 shares issued and outstanding at December 31, 2011
Additional paid-in capital
Accumulated surplus /(deficit)
Accumulated other comprehensive loss
Shareholders' equity
Total liabilities and shareholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support